JAK/STAT Signaling(JAK/STAT 信号通路)

Products for JAK/STAT Signaling
- Cat.No. 产品名称 Information
-
GC62385
Simotinib
Simotinib 是一种选择性、特异性、口服生物利用度高的 EGFR 酪氨酸激酶抑制剂,IC50 为 19.9 nM。抗肿瘤活性。
-
GC62384
Epitinib succinate
HMPL-813 succinate
Epitinib succinate 是一种具有口服活性和选择性的表皮生长因子受体酪氨酸激酶抑制剂 (EGFR-TKI),可以透过血脑屏障。Epitinib succinate 可用于癌症研究。 -
GC62341
Rezivertinib
BPI-7711
Rezivertinib (BPI-7711) 是一种口服有效,高选择性和不可逆的第三代 EGFR 酪氨酸激酶抑制剂 (TKI)。Rezivertinib 对常见的激活 EGFR 和抗性T790M 突变具有高效力。Rezivertinib 具有出色的透过中枢神经系统 (CNS) 能力,并具有抗肿瘤活性。 -
GC62313
Izencitinib
TD-1473; JNJ-8398
Izencitinib (TD-1473) 是具有口服活性的、非选择性的、肠道限定的 JAK 抑制剂。Izencitinib (TD-1473) 可用于溃疡性结肠炎研究。 -
GC62272
AC-4-130
AC-4-130 是一种有效的 STAT5 SH2 结构域抑制剂。AC-4-130 直接与 STAT5 结合并破坏 STAT5 激活、二聚化、核易位和 STAT5 依赖性基因转录。AC-4-130 在 FLT3-ITD 驱动的白血病细胞中诱导细胞周期停滞和细胞凋亡。AC-4-130 具有抗癌活性,可以有效阻断急性髓系白血病 (AML) 中 STAT5 活性的病理水平。
-
GC62254
Stafib-1
Stafib-1 是首个选择性的 STAT5b SH2 结构域的抑制剂,其 Ki 值为 44 nM,IC50 值为 154 nM。
-
GC62246
G5-7
G5-7 is an orally active and allosteric JAK2 inhibitor, selectively inhibits JAK2 mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3 by binding to JAK2.
-
GC62233
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide
A TYK2 inhibitor
-
GC62160
Mobocertinib succinate
莫博替尼琥珀酸盐; TAK-788 succinate; AP32788 succinate
An inhibitor of mutant EGFR and HER2 receptors -
GC62159
Tucatinib hemiethanolate
妥卡替尼半乙醇合物,Irbinitinib hemiethanolate; ARRY-380 hemiethanolate; ONT-380 hemiethanolate
An inhibitor of HER2 -
GC62130
(2R,5S)-Ritlecitinib
(2R,5S)-PF-06651600
(2R,5S)-Ritlecitinib (2R,5S)-PF-06651600) 是一种有效的选择性的 JAK3 抑制剂 (IC50=144.8 nM)。详细信息请参考专利US20150158864A1,example 68。 -
GC62112
Zotiraciclib
Zotiraciclib (SB1317; TG02) is a novel small molecule potent CDK/JAK2/FLT3 inhibitor, emerged with potent CDK (IC50 against CDKs 1, 2 and 9 = 9, 5 and 3 nM, respectively), FLT3 (IC50 = 19 nM) and JAK2 (IC50 = 19 nM) potency.
-
GC19747
CX-6258 HCl
Pim-Kinase Inhibitor X
A pan-Pim kinase inhibitor -
GC61807
(E/Z)-AG490
酪氨酸磷酸化抑制剂AG490,(E/Z)-Tyrphostin AG490; (E/Z)-Tyrphostin B42
(E/Z)-AG490((E/Z)-TyrphostinAG490)是(E)-AG490和(Z)-AG490的消旋体。(E)-AG490是一种酪氨酸激酶抑制剂,可抑制EGFR,Stat-3和JAK2/3。
-
GC61780
SU5204
SU5204 is a tyrosine kinase inhibitor with IC50 of 4 μM and 51.5 μM for FLK-1 (VEGFR-2) and HER2, respectively.
-
GC61627
Ochromycinone
抑胃酶氨酰-21,(Rac)-STA-21
Ochromycinone((Rac)-STA-21)是一种天然抗生素,也是一种STAT3抑制剂。Ochromycinone可抑制STAT3DNA结合活性,STAT3二聚化。Ochromycinone具有抗癌和抗菌活性。 -
GC61574
AS1810722
AS1810722是口服有效的STAT6抑制剂,IC50为1.9nM。AS1810722显示出良好的CYP3A4抑制作用。AS1810722是一种稠合双环嘧啶衍生物,具有用于过敏性疾病,例如哮喘和特应性疾病研究的潜力。
-
GC61524
SC-43
An SHP-1 activator
-
GC61490
Trastuzumab emtansine
曲妥珠单抗-美坦新偶联物; Ado-Trastuzumab emtansine; PRO132365; T-DM 1
Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa. -
GC61473
Trastuzumab deruxtecan
DS-8201 (solution); DS-8201a (solution)
Trastuzumab deruxtecan(曲妥珠单抗)是一种人表皮生长因子受体2(HER2)靶向抗体-药物偶联物(ADC),由人源化抗人HER2(抗hHER2)抗体、酶促裂解肽接头和拓扑异构酶I抑制剂(DX-8951衍生物)组成。 -
GC48839
Nifuroxazide-d4
硝呋齐特 d4
An internal standard for the quantification of nifuroxazide -
GC50706
JBJ-03-142-02
Highly potent epidermal growth factor receptor (EGFR) and ErbB2 (human epidermal growth factor receptor; HER2) inhibitor
-
GC47303
Erlotinib-d6 (hydrochloride)
埃罗替尼-D6盐酸盐,CP-358774-d6 hydrochloride; NSC 718781-d6 hydrochloride; OSI-774-d6 hydrochloride
An internal standard for the quantification of erlotinib -
GC47061
CAY10763
A dual inhibitor of IDO1 and STAT3 activation
-
GC46503
2-(1,8-Naphthyridin-2-yl)phenol
3-氨基-2-氯-6-三氟甲基吡啶
An enhancer of STAT1 activity -
GC61161
Osimertinib D6
AZD-9291-d6; Mereletinib-d6
OsimertinibD6(AZD-9291D6)是Osimertinib的一种氘代化合物。Osimertinib是一种不可逆和突变的选择性的EGFR抑制剂,抑制EGFRL858R和EGFRL858R/T790M的IC50分别为12和1nM。 -
GC60868
Gefitinib D8
吉非替尼杂质-D8,ZD1839-d8
GefitinibD8(ZD1839D8)是Gefitinib的氘代物。Gefitinib是一种有效的(EGFR)抑制剂,在NR6wtEGFR细胞中IC50值为2-37nM。 -
GC60805
EMI48
EMI48是EMI1的衍生物,EMI48比EMI1对突变型EGFR具有更大的效力。EMI48抑制EGFR三重突变体。
-
GC60586
Angoline hydrochloride
Angolinehydrochloride是一种有效的选择性的IL6/STAT3信号通路抑制剂,IC50为11.56μM。Angolinehydrochloride抑制STAT3磷酸化及其靶基因表达,并抑制癌细胞增殖。
-
GC60585
Angoline
6-甲氧基二氢白屈菜红碱
Angoline是一种有效的选择性的IL6/STAT3信号通路抑制剂,IC50为11.56μM。Angoline抑制STAT3磷酸化及其靶基因表达,并抑制癌细胞增殖。 -
GC60567
Afatinib impurity 11
Afatinib impurity 11 is an impurity of afatinib, an EGFR family inhibitor.
-
GC60154
Erlotinib D6
CP-358774-d6; NSC 718781-d6; OSI-774-d6
An internal standard for the quantification of erlotinib -
GC39485
CK2/ERK8-IN-1
A dual inhibitor of CK2 and ERK8
-
GC50480
PF 06651600 malonate
Potent and selective JAK3 inhibitor
-
GC50343
HJC 0416 hydrochloride
HJC 0416 hydrochloride 是一种有效的口服活性 STAT3 抑制剂,具有比 Stattic 更强的抗癌特性。 HJC 0416 hydrochloride 是一种用于乳腺癌研究的有前途的抗癌剂。
-
GC50083
PKI 166 hydrochloride
An inhibitor of EGFR
-
GC50066
Atiprimod dihydrochloride
JAK2 inhibitor
-
GC50026
BIBX 1382 dihydrochloride
An EGFR inhibitor
-
GC50013
AG 1478 hydrochloride
N-(3-氯苯基)-6,7-二甲氧基-4-喹唑啉胺盐酸盐,Tyrphostin AG-1478 hydrochloride; NSC 693255 hydrochloride
An inhibitor of EGF receptor kinase -
GC39081
Reticuline
番荔枝碱
Reticuline 分离自 Litsea cubeba,通过 JAK2/STAT3 和 NF-κB 信号通路显示抗炎作用。Reticuline 还可抑制 TNF-α 和 IL-6 的 mRNA 表达,并降低 JAK2 和 STAT3 的磷酸化水平。 -
GC39022
Tetramethylcurcumin
四甲基姜黄素; FLLL31
Tetramethylcurcumin (FLLL31), a small-molecule signal transducer and activator of transcription 3 (STAT3) inhibitor derived from curcumin, binds selectively to Janus kinase 2 and the STAT3 Src homology-2 domain, which serve crucial roles in STAT3 dimerization and signal transduction. -
GC38737
AS2863619 free base
A dual inhibitor of Cdk8 and Cdk19
-
GC38736
AS2863619
A dual inhibitor of Cdk8 and Cdk19
-
GC45756
Pimozide-d4
R6238-d4
An internal standard for the quantification of pimozide -
GC38402
BI-4020
BI-4020 is an orally active, non-covalent EGFR inhibitor with IC50 of 0.6 nM and 0.2 nM for EGFRdel19 T790M C797S as biomarker potency and anti-proliferation potency in BaF3 cells, respectively.
-
GC38386
Golotimod hydrochloride
SCV 07 hydrochloride; Gamma-D-glutamyl-L-tryptophan hydrochloride
Golotimod hydrochloride (SCV 07 hydrochloride) 一种具有抗菌活性的免疫调节肽,可显着提高抗结核治疗的功效,刺激胸腺和脾细胞增殖,并改善巨噬细胞功能。Golotimod hydrochloride (SCV 07 hydrochloride) 抑制 STAT3 信号传导并调节接受放疗或放疗与顺铂联合用药的动物模型中口腔粘膜炎的持续时间和严重程度。Golotimod hydrochloride (SCV 07 hydrochloride) 是复发性生殖器单纯疱疹病毒 2 型 (HSV-2) 的潜在治疗药物。 -
GC38350
Epertinib hydrochloride
S-22611 hydrochloride
Epertinib hydrochloride (S-222611 hydrochloride) is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4 with IC50 of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib hydrochloride (S-222611 hydrochloride) exhibits antitumor activity. -
GC38180
Cyasterone
杯苋甾酮
Cyasterone,一种天然的 EGFR 抑制剂,主要分离自 Ajuga decumbens Thunb (Labiatae)。Cyasterone 通过诱导细胞凋亡 (apoptosis) 和细胞周期阻滞表现出抗增殖作用。 Cyasterone 可作为抗人类肿瘤的临床治疗性药物。 -
GC38125
Tyrphostin AG30
酪氨酸磷酸化抑制剂AG30,AG30
Tyrphostin AG30 (AG30), a potent and selective EGFR tyrosine kinase inhibitor, selectively inhibits self renewal induction by c-ErbB, and is able to inhibit activation of STAT5 by c-ErbB in primary erythroblasts. -
GC38081
Theliatinib
西利替尼; Xiliertinib; HMPL-309
Theliatinib (HMPL-309) is a highly potent EGFR inhibitor with Ki value of 0.05 nM against the wild type EGFR and IC50 values of 3 nM and 22 nM against EGFR and EGFR T790M/L858R mutant. It demonstrats 50 fold greater selectivity for EGFR compared to 72 other kinases.